Exact Sciences Stock News

One of the best-known and well-covered ETF companies over the past five years has been ARK Invest, led by Cathie Wood. With the funds falling over the past year and hitting new lows, Benzinga asked w

This top medical diagnostic stock took a big haircut in 2021.

This top medical diagnostic stock took a big haircut in 2021.

This top medical diagnostic stock took a big haircut in 2021.

Exact Sciences Corp (NASDAQ: EXAS ) has put down $190 million to buy testing laboratory PreventionGenetics , aiming to expand its diagnostics franchise into hereditary cancer screening. PreventionGenetics offers more than 5,000 DNA tests, including germline and whole-exome sequencing panels, to help users identify potential risks they may have inherited for developing cancer or other diseases. Calling the deal a "natural fit," Exact Sciences CEO Kevin Conroy said the Company''s genetic tests would help catch tumors earlier when treatments can Full story available on Benzinga.com

Exact Sciences (EXAS) has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support entrance into hereditary

Exact Sciences (EXAS) closed the most recent trading day at $75.66, moving +1.42% from the previous trading session.

Exact Sciences (EXAS) closed the most recent trading day at $75.66, moving +1.42% from the previous trading session.

Cate Faddis of Grace Capital says there are plenty of opportunities for investors to snap up some of the beaten-down names in the healthcare space and among recent IPOs.

Exact Sciences (EXAS) is planning several key milestones to bring six innovative cancer diagnostics from its pipeline to patients in need.

Exact Sciences (EXAS) is planning several key milestones to bring six innovative cancer diagnostics from its pipeline to patients in need.

Banque Cantonale Vaudoise increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS) by 14.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,275 shares of the medical research company’s stock after acquiring an additional 555 shares during the quarter. […] The post Exact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Banque Cantonale Vaudoise appeared first on ETF Daily News .

Wright Investors Service Inc. bought a new stake in Exact Sciences Co. (NASDAQ:EXAS) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 7,950 shares of the medical research companys stock, valued at approximately $758,000. Several other hedge funds and other institutional []

Related Stocks: DFS , FANG , PGNY , RCL , BILL , SGEN , AVLR , TECH , ROKU , FOUR , PINS , LPLA , VEEV , PCTY , TTWO , ELS , SPOT , ZEN , FICO , FIVN , NVRO , EXAS ,